Section Review Central & Peripheral Nervous Systems: Treatment for alcohol withdrawal: recent developments

References

• HUNT W: Neuroscience research: how has it contributed to our understanding of alcohol abuse and alcoholism?a review. Alcohol. Clin. Exp. Res. (1993) 17(5):1055–1065. This paper thoroughly reviews the advances in neuropharmacology of ethanol.
   Google Scholar
• LERNER WI), FALLON HJ: The alcohol withdrawal syn-drome. New Engl.J. Med. (1985) 313:951–952.
   PubMed Web of Science ®Google Scholar
• GOLBERT TM, SANZ CJ, ROSE HD, LEITSCHUH TH: Com-parative evaluation of treatments of alcohol withdrawal syndromes. JAMA (1967) 201:113–116.
   Web of Science ®Google Scholar
• KAIM SC, KLETT CJ, ROTHFELD B: Treatment of the acute withdrawal state: a comparison of four drugs. Am. J. Psychiatry(1969) 125:1640–1646.
   PubMed Web of Science ®Google Scholar
• This is one of the first reports of BZD use in alcohol withdrawal.
   Google Scholar
• SELLERS EM, KALANT H: Alcohol intoxication and with-drawaL New Engl.J. Med. (1976) 294:757–762.
   Google Scholar
• HALLOWAY HC, HALES RE, WATANABE HK: Recognition and treatment of alcohol withdrawal syndromes. Psy-chiatr. Clin. North Am. (1984) 7:729–743.
   PubMed Web of Science ®Google Scholar
• NARANJO CA, SELLERS EM: Clinical assessment and phar-macotherapy of the alcohol withdrawal syndrome. Re-cent Developments in Alcoholism (Chapter 12). Galanter M (Ed.). Plenum Press, New York (1986):265–281.
   Google Scholar
• ROMACH MK, SELLERS EM: Management of the alcoholwithdrawal syndrome. Ann. Rev. Med. (1991) 42:323–340.
   PubMed Web of Science ®Google Scholar
• LISKOW BI, GOODWIN DW: Pharmacological treatmentof alcohol intoxication, withdrawal, and dependence: a critical review. J. Stud. Alcohol, (1987) 48:356–370.
   PubMed Web of Science ®Google Scholar
• ROSENBLOOM AJ: Emerging treatment options in thealcohol withdrawal syndrome. J. Clin. Psychiatry (1988) 12(Suppl.):28–31.
   Google Scholar
• MILLER WC, MCCURDY L: A double-blind comparison ofthe efficacy and safety of lorazepam and diazepam in the treatment of the acute alcohol withdrawal syn-drome. Clin. Therapeutics (1984) 6:365–371.
   Google Scholar
• SAITZ R, MAYO-SMITH MF, ROBERTS MS, REDMOND HA, BERNARD DR, CALKINS DR: Individualized treatment for alcohol withdrawal: a randomized double-blind con-trolled trial. JANIA (1994) 272:519–523.
   PubMed Web of Science ®Google Scholar
• This paper is an example of a well designed clinical trial for alcohol withdrawal.
   Google Scholar
• SELLERS EM, NARANJO CA, HARRISON M, DEVENYI P, ROACH C, SYKORA K: Oral diazepam loading: simplified treatment of alcohol withdraw-aL Clin. Pharmacol. Ther. (1983) 34:822–826.
   Web of Science ®Google Scholar
• NEWMAN JP, TERRIS DJ, MOORE M: Trends in the man-agement of alcohol withdrawal syndrome. Laryngoscope (1995) 105(1):1–7.
   PubMed Web of Science ®Google Scholar
• GREENBLATT DJ, SHADER RI, ABERNETHY DR: Currentstatus of benzodiazepines. New Engl. J Med. (1983) 309:354–358.
   PubMed Web of Science ®Google Scholar
• GREENBLATT DJ, DIVOLL M, ABERNETHTY DR, OCHS HR, SHADER RI: Benzodiazepines kinetics: implications for therapies and pharmacogeriatrics. Drug Metab. Rev. (1983) 14:251–292.
   PubMed Web of Science ®Google Scholar
• This paper is an important review of BZD pharmacokinetic studies.
   Google Scholar
• GREENBLATT DJ, SHADER RI, KOCH-WESER J: Slow ab-sorption of intramuscular chlordiazepoxide. New Engl. J. Med. (1974) 291:1116–1118.
   PubMed Web of Science ®Google Scholar
• LINEAWEAVER WC, ANDERSON K, HING DN: Massive doses of midazolam infusion for delirium tremens without respiratory depression. Crit. Care Med. (1988) 16:294–295.
   PubMed Web of Science ®Google Scholar
• NOLOP KB, NATOW A: Unprecedented sedative require-ments during delirium tremens. Crit. Care Med. (1985) 13:246–247.
   PubMed Web of Science ®Google Scholar
• REEVES JG, FRAGEN RJ, VINIK R, GREENBLATT DJ: Mida- zolam: pharmacology and uses. Anesthesiology (1985) 62:310–324.
   PubMed Web of Science ®Google Scholar
• This paper provides an in depth review of midazolam.
   Google Scholar
• CALLLE G, LACASSE S, BRENNAN J: Pharmacokinetics oftwo lorazepam formulations, oral and sublingual after multiple doses. Biopharm. Drug Dispos. (1983) 4:31–42.
   PubMed Web of Science ®Google Scholar
• DUNTON AW, SCHWAM E, PITMAN V, MCGRATH J, HEND LER J, SIEGEL J: Flumazenik US clinical pharmacol-ogy studies. Eur. J. Anaesthesiol. (1988) B(Suppl.):81–95.
   Google Scholar
• MAJUMDAR SK: Chlormethiazole: current status in the treatment of the acute ethanol withdrawal syndrome. Drug and Alcohol Dependence (1990) 27:201–207.
   Web of Science ®Google Scholar
• This paper summarises the use of chlormethiazole in Europe.
   Google Scholar
• HORDER jM: Fatal chlormethiazole poisoning in chronic alcoholics. Br. Med. J. (1978) 1:693–694.
   PubMed Web of Science ®Google Scholar
• MCINNES GT: Chlormethiazole and alcohol: a lethal cocktail. Br. Med. J. (1987) 294:592.
   PubMed Web of Science ®Google Scholar
• FISHER DK, SIMPSON RK, SMITH KA, MATTOX KL: Efficacyof dexamethasone in benzodiazepine-resistant delir-ium tremens. Lancet (1988) 1:1340–1341.
   Web of Science ®Google Scholar
• POL S, NALPAS B, BERTHELOT P: Dexamethasone foralcohol withdrawal Ann. Intern. Med. (1991) 114:705–706.
   Google Scholar
• DAVID° A, CADRANEL JF, LEVY A, BENHAMOU Y, GAR-GOT D, LEPLAT P, VALLA D, OPOLON P: Effects of Intravenous administration of dexamethasone in the treatment of alcohol withdrawal syndrome. J. Clin. Gastroenterol. (1994) 18:178–179.
   PubMed Web of Science ®Google Scholar
• FISH DN: Treatment of delirium in the critically ill patient. Clin. Pharm. (1991) 10: 456–466.
   PubMedGoogle Scholar
• This paper reports on efficacy of haloperidol as an adjunct to BZD use.
   Google Scholar
• BAUMGARTNER GR, ROWEN RC: Transdermal clonidineversus chlordiazepoxide in alcohol withdrawal: a ran-domized controlled clinical trial. South. Med. J. (1991) 84:312–321.
   PubMed Web of Science ®Google Scholar
• KRAUS ML, GOTFLEIB LD, HORWITZ RI, ANSCHER M: Randomized clinical trial of atenolol in patients with alcohol withdrawaL New Engl. J. Med. (1985) 313:905–909.
   Google Scholar
• MALCOM R, BALLENGER JC, STURGIS ET, ANTON R: Dou-ble-blind controlled trial comparing carbama7epine to oxazeparn treatments of alcohol withdrawal. Am. J. Psychiatry (1989) 146:617–621.
   PubMedGoogle Scholar
• STUPPPAECK CH, PYCHA R, MILLER C, WHITWORTH AB, OBERBAUER H, FLEISCHACKER WW: Carbamazepine ver-sus oxazepam in the treatment of alcohol withdrawal: a double blind study. Alcohol. Alcohol (1992) 27:153–158.
   PubMed Web of Science ®Google Scholar
• TSAI G, GASTFRIEND DR, COYLE JT: The glutamatergic basis of human alcoholism. Am. J. Psychiatry (1995) 152(3):332–340.
   PubMed Web of Science ®Google Scholar
• This paper provides a comprehensive review of glutamate-ethanol interactions.
   Google Scholar
• LEMARQUAND D, PIHL RO, BENKELFAT C: Serotonin and alcohol intake, abuse, and dependence: clinical evi-dence. Biol. Psychiatry (1994) 36:326–337.
   PubMed Web of Science ®Google Scholar
• This paper examines the potential role of serotonin in the prevention of alcoholism.
   Google Scholar
• KORPI ER: Role of GAI3AA receptors in the actions of alcohol and in alcoholism: recent advances. Alcohol. Alcohol (1994) 29(2):115–129.
   PubMed Web of Science ®Google Scholar
• This paper includes reviews of inverse agonist and insights into pharmacological mechanisms of alcohol withdrawal.
   Google Scholar
• SELLARS EM, TONEATTO T, ROMACH MK, SOMER GR, SOBELL GR, SOBELL, MB: Clinical efficacy of the 5-HT3 antagonist ondansetron in alcohol abuse and depend-ence. Alcohol. Clin. Exp Res. (1994) 18:879–885.
   PubMed Web of Science ®Google Scholar
• KOPPI S, EBERHARDT G, HALLER R, KONIG P. Calciumchannel-blocking agent in the treatment of acute alco-hol withdrawal - caroverine versus meprobamate in a randomized double-blind study. Neuropsychobiology (1987) 17:49–52.
   PubMed Web of Science ®Google Scholar
• BONE GH, MAJCHROWICZ E, MARTIN PR, LINNOILA M, NUTT DJ: A comparison of calcium antagonist and diazepam in reducing ethanol withdrawal tremors. Pyschopharmacology (1989) 99:386–388.
   PubMed Web of Science ®Google Scholar
• BUCK KJ, HARRIS RA: Benzodiazepine agonist and in-verse agonist actions on GABAA receptor-operated chlo-ride channels. II. Chronic effects of ethanoL J. Pharmacol. Exp. Ther. (1990) 253:713–719.
   PubMed Web of Science ®Google Scholar
• HUMENIUK RE, WHITE JM, ONG J: The effects of GABAB ligands on alcohol withdrawal in mice. Pharmacol. Bio-chem. Behav. (1994) 49:561–566.
   Google Scholar
• MOSKO'WITZ G, CHALMERS TC, SACKS HS, FAGERSTROM RM, SMITH H. Deficiencies of clinical trials of alcohol withdrawaL Alcohol. Clin. Exp. Res. (1983) 7:42–46.
   PubMed Web of Science ®Google Scholar
• SULLIVAN JT, SYKORA K, SCHNEIDERMAN J, NARANJO CA, SELLERS EM. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br. J. Addict. (1989) 84:1353-1357. This paper summarises the most current objective assessment scale in clinical use for AWS.
   Google Scholar